Last updated: 25 March 2020 at 4:43pm EST

Louis O'dea Net Worth




The estimated Net Worth of Louis O'dea is at least $1.16 Milion dollars as of 23 March 2020. Louis dea owns over 3,198 units of Akcea Therapeutics Inc stock worth over $1,119,308 and over the last 7 years Louis sold AKCA stock worth over $37,577.

Louis dea AKCA stock SEC Form 4 insiders trading

Louis has made over 1 trades of the Akcea Therapeutics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Louis sold 3,198 units of AKCA stock worth $37,577 on 23 March 2020.

The largest trade Louis's ever made was selling 3,198 units of Akcea Therapeutics Inc stock on 23 March 2020 worth over $37,577. On average, Louis trades about 457 units every 0 days since 2018. As of 23 March 2020 Louis still owns at least 61,602 units of Akcea Therapeutics Inc stock.

You can see the complete history of Louis dea stock trades at the bottom of the page.



What's Louis dea's mailing address?

Louis's mailing address filed with the SEC is C/O AKCEA THERAPEUTICS, INC., 22 BOSTON WHARF ROAD, 9TH FLOOR, BOSTON, MA, 02210.

Insiders trading at Akcea Therapeutics Inc

Over the last 7 years, insiders at Akcea Therapeutics Inc have traded over $384,023 worth of Akcea Therapeutics Inc stock and bought 35,029,381 units worth $610,464,515 . The most active insiders traders include Pharmaceuticals Inc Ionis, Paula Soteropoulos oraz B Lynne Parshall. On average, Akcea Therapeutics Inc executives and independent directors trade stock every 69 days with the average trade being worth of $40,228,816. The most recent stock trade was executed by Pharmaceuticals Inc Ionis on 10 October 2020, trading 21,237,715 units of AKCA stock currently worth $385,464,527.



What does Akcea Therapeutics Inc do?



Complete history of Louis dea stock trades at Akcea Therapeutics Inc

Osoba
Trans.
Transakcja
Łączna cena
Louis O'dea
Chief Medical Officer
Sprzedaż $37,577
23 Mar 2020


Akcea Therapeutics Inc executives and stock owners

Akcea Therapeutics Inc executives and other stock owners filed with the SEC include: